Independent Advisor Alliance’s Mangoceuticals MGRX Stock Holding History

Independent Advisor Alliance’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-667	Closed	-$8.51K	–	695
2023 Q3	$8.51K	Sell	667 -1,066	-62%	-$19.9K	﹤0.01%	647
2023 Q2	$47.6K	Buy	+1,733	New	+$34.2K	﹤0.01%	650

Other funds holding MGRX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

Vanguard Capital Wealth Advisors Denver, Colorado $148M AUM 91.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Independent Advisor Alliance's MGRX Position: Q4 2023 in Review

Independent Advisor Alliance sold out of Mangoceuticals (MGRX) in Q4 2023, closing a stake of 667 shares — an estimated $8.51K sold.

Independent Advisor Alliance first reported a position in MGRX in Q2 2023 and held it in 2 quarters. The position peaked at $47.6K in Q2 2023. 5 funds tracked by Wall St. Rank hold MGRX as of Q4 2023.

Independent Advisor Alliance reported no remaining Mangoceuticals position as of Q4 2023 after selling out during the quarter.
Independent Advisor Alliance sold 667 Mangoceuticals shares in Q4 2023, an estimated $8.51K.
Independent Advisor Alliance first reported a position in Mangoceuticals in Q2 2023 and held it in 2 quarters.
Independent Advisor Alliance's Mangoceuticals position peaked at $47.6K in Q2 2023.
5 funds tracked by Wall St. Rank held Mangoceuticals as of Q4 2023.

Based on Independent Advisor Alliance's 13F filing for Q4 2023, filed 8 Feb 2024.